GSK3B and diabetes mellitus: Though more work will be needed to reveal the PI3K/AKT/GSK3β-involved accurate mechanism of action regulated by N-p-CO, the present findings clearly demonstrate that N-p-CO is exploitable as a new candidate for the prevention and treatment of diabetes.